ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $286,000 | -34.3% | 4,309 | -38.2% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | -55.8% | 6,967 | -41.4% | 0.00% | -50.0% |
| Q2 2021 | $984,000 | +42.4% | 11,882 | +14.0% | 0.00% | 0.0% |
| Q1 2021 | $691,000 | -24.8% | 10,425 | -13.0% | 0.00% | 0.0% |
| Q4 2020 | $919,000 | +184.5% | 11,982 | +59.8% | 0.00% | +100.0% |
| Q3 2020 | $323,000 | -50.5% | 7,499 | -50.4% | 0.00% | -50.0% |
| Q2 2020 | $653,000 | -66.6% | 15,127 | -77.7% | 0.00% | -81.8% |
| Q1 2020 | $1,954,000 | -78.6% | 67,923 | -52.9% | 0.01% | -76.6% |
| Q4 2019 | $9,138,000 | +86.0% | 144,067 | -17.4% | 0.05% | +56.7% |
| Q3 2019 | $4,914,000 | – | 174,380 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |